Abstract
At present, there are no clinically reliable disease markers for chronic fatigue syndrome. DNA chip microarray technology provides a method for examining the differential expression of mRNA from a large number of genes. Our hypothesis was that a gene expression signature, generated by microarray assays, could help identify genes which are dysregulated in patients with post-infectious CFS and so help identify biomarkers for the condition.
Original language | English |
---|---|
Journal | BMC Medical Genomics |
Volume | 2 |
Issue number | 38 |
DOIs | |
Publication status | Published - 1 Jun 2009 |
Keywords
- post-infectious chronic fatigue syndrome
- gene signature